Subject: Who Is Not Fit To Practice Medicine?
Date: Wed, 09 May 2012 13:24:54 -0400
From: Veracare <email@example.com>
Alliance for Human Research Protection (AHRP)
Advancing Honest and Ethical Medical Research
A British Parliamentary Committee Report deemed Rupert Murdoch "not a
fit person" to run a major news reporting company based on his
organizations illegal phone hacking activities.
Here is a compelling reason why psychiatrists who prescribe antipsychotic drugs are "not fit" to practice medicine.
At a minimum, the practice of responsible medicine requires that
physicians who prescribe drugs whose known severe adverse side effects
are likely to cause their patients irreversible harm, requires that
those physicians follow monitoring guidelines to ensure their patients'
The second generation neuroleptics (antipsychotics such as Clozaril,
Zyprexa, Risperdal, Guiedon, Seroquel, Abilify) are known to cause
severe, potentially lethal adverse effects. These include rapid
metabolic changes, including acute weight gain, and interference with
normal glucose metabolism. These changes lead to increased rates of
cardiovascular disease and premature deaths.
In 2003, the FDA required a warning label about the diabetes risk for
people prescribed second-generation antipsychotic drugs. The American
Diabetes Association and the American Psychiatric Association (APA)
recommended glucose and lipid screening and monitoring for all patients
starting these drugs.
The drugs are widely misprescribed even for young children, whose safety
is at high risk from those drug-induced metabolic changes.
Yet, studies examining monitoring rates for patients--young and old--who
are prescribed these drugs, have consistently shown that psychiatrists
fail to screen or monitor for either glucose or lipid levels in patients
for whom they prescribe these drugs. In 2008, Dr. Dan Haupt of
Washington University, St. Louis, found that only 20% of patients
prescribed antipsychotics were monitored for glucose levels, and only
10% had their lipids monitored.
The latest such study (Abstract NR7-51) was presented by Dr. Christina
Mangurian, a University of California at San Francisco psychiatrist, at
the Annual Meeting of the American Psychiatric Association, May 7,
2012. Her findings confirm the lack of metabolic screening and
monitoring of patients prescribed antipsychotic drugs by
psychiatrists--even as psychiatrists acknowledged that they should be
doing the monitoring.
Dr. Haupt suggested that psychiatry suffers from an "identity crisis," noting that:
"Historically these are people who have gone to medical school but
have not viewed themselves as physicians in the same way as an internist